When is RightSmile’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is RightSmile overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does RightSmile pay dividends?
RightSmile does not currently pay dividends.
What is RightSmile’s EPS estimate?
RightSmile’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does RightSmile have?
RightSmile has 3,594,207,000 shares outstanding.
Which hedge fund is a major shareholder of RightSmile?
Currently, no hedge funds are holding shares in RIGH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
RightSmile
Bud Genius, Inc. specializes in the analytical testing and characterization of cannabis. Additionally, the company offers cloud-hosted health technology, facilitating the real-time transfer of health metrics from mobile devices to healthcare providers and naturopathic doctors. Its services also encompass managing product licensing agreements with celebrity endorsements, as well as providing retail display and promotional services. Furthermore, Bud Genius develops data-informed evaluation systems for various cannabis strains and products. The company operates from its base in Carlsbad, California.